AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

A network based efficient drug repurposing strategy for targeting diabesity

Subhajit Duttaa, Ted Natolib, Deep Chandaa, Sindhuja Rajavelua, Debojyoti Dea( )
Laboratory of Cellular Differentiation & Metabolic Disorder, Department of Biotechnology, National Institute of Technology, Durgapur, West Bengal 713209, India
Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Pages 340-343

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Dutta S, Natoli T, Chanda D, et al. A network based efficient drug repurposing strategy for targeting diabesity. Genes & Diseases, 2023, 10(2): 340-343. https://doi.org/10.1016/j.gendis.2022.02.015

767

Views

7

Downloads

2

Crossref

2

Web of Science

4

Scopus

0

CSCD

Received: 14 December 2021
Published: 28 March 2022
© 2022 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).